• Esperion Therapeutics' (ESPR) "Buy" Rating Reiterated at HC Wainwright

    Source: Buzz FX / 05 Mar 2025 10:56:14   America/Chicago


    Esperion Therapeutics' (ESPR) "Buy" Rating Reiterated at HC Wainwright Written by MarketBeat March 5, 2025 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "buy" rating restated by ana
    Read more...
Share on,